This journal evaluates the Oregon HOPE TeleHCV study, a peer-facilitated telemedicine model (Peer TeleHCV) for hepatitis C virus (HCV) treatment among people who use drugs (PWUD) in rural Oregon. The findings highlight high patient satisfaction and key factors that enhanced implementation, demonstrating the model’s potential to reduce barriers and improve treatment access.
Contact organization for eligibility
Contact organization for eligibility
This video reviews the five stages of integrated planning and emphasizes the invaluable role that community and partner engagement plays in integrated planning and thus ensuring a responsive, reflective, and comprehensive Integrated HIV Prevention and Care Plan.
This video provides a brief background on integrated planning and how a joint HIV prevention and care planning process supports a collaborative and inclusive integrated system of care.
This webpage explores the risks of untreated hepatitis C, highlighting its potential to cause severe liver damage, cirrhosis, liver failure, and even liver cancer. Beyond liver-related issues, the virus can also contribute to complications such as fatigue, joint pain, kidney disease, and diabetes. Early diagnosis and treatment are essential to preventing these long-term health risks and improving overall well-being.
This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.
Contact organization for eligibility
Contact organization for eligibility
Contact organization for eligibility
